Target intelligence / Profile preview

Essential meiotic structure-specific endonuclease 1 (EME1)

Target
EME1
Molecular classification
Enzyme, Structure-specific endonuclease, DNA repair protein
01

Overview

Essential meiotic structure-specific endonuclease 1 (EME1) is a structure-specific endonuclease that forms a functional complex with MUS81, participating in the cleavage and resolution of branched DNA structures such as nicked Holliday junctions, 3'-flaps, and stalled replication forks. This endonuclease complex plays a critical role in DNA damage repair—especially processing intermediates of homologous recombination and resolving DNA structures at stalled or collapsed replication forks—and is essential for maintaining genomic integrity. Its activity is tightly regulated by phosphorylation and protein-protein interactions, and it is particularly vital when other repair pathways (e.g., those involving the BLM helicase) are compromised[1][2][3][4][5].

Other names
Structure-specific endonuclease subunit EME1MMS4hMMS4FLJ31364MMS4LSLX2ACrossover junction endonuclease EME1MMS4 homologSLX2 structure-specific endonuclease subunit homolog A (S. cerevisiae)structure-specific endonuclease subunit EME1SLX2 structure-specific endonuclease subunit homolog Acrossover junction endonuclease EME1essential meiotic endonuclease 1 homolog 1essential meiotic endonuclease 1 homolog 2homolog of yeast EME1 endonuclease
02

Mechanism of action

DNA-damaging agents induce replication stress that requires EME1-mediated processing for cell survival; EME1 is part of a critical DNA repair endonuclease complex (often with MUS81) that cuts branched DNA structures to facilitate DNA repair[2][3]

03

Biological functions

DNA repairMaintenance of genomic stabilityCell cycle (S phase regulation)Processing of DNA recombination intermediatesResolution of stalled or collapsed replication forks
04

Disease associations

CancerXeroderma pigmentosum group FInterstitial nephritis (Karyomegalic)Other DNA-repair disorders
05

Safety considerations

Loss of EME1 function results in hypersensitivity to DNA cross-linking agents and increased genomic instability, posing challenges for developing inhibitors; targeting EME1 may affect normal cell DNA repair and raise risk of chromosomal aberrations[1][2]
06

Interacting drugs

None documented as directly targeting EME1; potential indirect modulation by DNA-damaging agents (e.g., mitomycin C, cisplatin)[2]
07

Biomarkers

No established direct biomarkers for patient selection or efficacy monitoring for EME1 as of now; its activity/state may be relevant as a marker of DNA repair competency in research contexts

Beyond the preview

Go deeper on Essential meiotic structure-specific endonuclease 1 (EME1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Essential meiotic structure-specific endonuclease 1 (EME1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call